Publications by authors named "Samantha Heacock"
Article Synopsis
- This study compared the effects of oral versus injectable semaglutide on hemoglobin A (HbA) levels and weight in patients with type 2 diabetes (T2D), as there is limited existing data on the two formulations.
- Over a 6-month period, patients taking oral semaglutide had a slightly greater reduction in HbA, while injectable semaglutide resulted in a greater weight loss.
- Adverse events were more common in the oral group, leading to more discontinuations, highlighting the need for careful consideration when choosing between these formulations.
Background: Limited real-world data on the benefits and risks associated with 3 and 4.5 mg doses of dulaglutide currently exists, making it difficult to determine the impact of dose titration for patients currently managed with dulaglutide 1.5 mg weekly.
View Article and Find Full Text PDF